Skip to main content
Equibles
DHC logo

DHC · Diversified Healthcare Trust · Metrics

Track DHC — free

Use DHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.88 +0.01 (+0.13%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.91B
Shares
242.13M
Volume · Oct 23 27.2K Avg daily vol (3M) 1.81M

DHC metrics

77 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.87
Market cap
$1.91B

Price action

20 metrics
Price change (1W)
+3.4%
Price change (30D)
-3.7%
Price change (3M)
-14.8%
Price change (6M)
+10.8%
Price change (YTD)
+62.3%
Price change (1Y)
+86.9%
Trailing year
Price change (5Y)
+111.0%
52-week high
$9.64
52-week low
$4.10
Change from 52-week high
-18.4%
Change from 52-week low
+92.0%
Annualized volatility
38.4%
Annualized volatility (3M)
29.3%
Beta
0.6
RSI (14D)
54.8
Price vs SMA 50
+0.7%
Price vs SMA 200
+2.2%
Avg volume (3M)
1.81M
Relative volume
1.0
Average dollar volume
$14.61M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
242.13M

Valuation

14 metrics
P / FFO
22.9×
Company-stated · TTM · reciprocal yield 4.4%
P / AFFO
—
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.8×
reciprocal yield 35.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 78.7%
P / book
1.2
reciprocal yield 83.1%
FCF yield
—
TTM · current market cap
Buyback yield
0.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
-14.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.6×
reciprocal yield 39.2%
EV / revenue historical average (5Y)
2.6×
reciprocal yield 39.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
—
Shareholder yield
0.6%
Dividend / share (TTM)
$0.05
Dividend growth YoY
+25.0%
Dividend growth streak
0
Last ex-dividend
2026-10-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-17.7%
Gross profit (TTM)
—
Operating profit (TTM)
$273.05M
Net income (TTM)
−$265.95M
Trailing 12 months
Diluted EPS (TTM)
$-1.11
FCF margin
—
Effective tax rate
—

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$6.23
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.15
EBITDA per diluted share (TTM)
$2.31
Net income per diluted share (TTM)
$-1.11
Operating cash flow per diluted share (TTM)
$-0.09
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.88

Growth

11 metrics
Revenue growth YoY
-4.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.50B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+6.2%
Revenue CAGR (5Y)
-1.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-16.8%
Return on assets
-6.3%
Debt / equity
1.5
Current ratio
—
EBITDA (TTM)
$549.70M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.33B
Latest balance sheet
Cash & equivalents
$116.79M
Total assets
$4.24B
Total debt
$2.44B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.67M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
241
13F filer change QoQ
+6
Institutional ownership
85.3%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
37.1%
Private-fund adviser ownership
36.6%
Active holders' share change QoQ
+2.9%
Holder tenure
13.6
Price vs estimated holder cost
+118.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.0%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1075415 CUSIP 25525P107 13F (30d) 30 filings 30 filers Visit website Investor relations